Related Experiment Video
Updated: Nov 6, 2025
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
11.3K
Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes.
Teresa Rodriguez-Calvo1, Yi-Chun Chen2, C Bruce Verchere3
1Institute of Diabetes Research, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health, Munich-Neuherberg, Germany.
Diabetes
|May 5, 2021
Summary
Reduced prohormone processing is an early sign in type 1 diabetes (T1D). Understanding these changes could lead to new biomarkers for personalized T1D therapies and disease endotypes.
Area of Science:
- Endocrinology
- Immunology
- Metabolic Diseases
Background:
- Reduced islet prohormone processing is an early, persistent finding in type 1 diabetes (T1D).
- This alteration affects insulin production and secretion in pancreatic islets.
- Understanding these changes is crucial for T1D pathogenesis.
Purpose of the Study:
- To review current knowledge on islet prohormone expression and processing in T1D.
- To discuss the clinical impact of these alterations.
- To identify future research directions.
Main Methods:
- Review of clinical cohort data and human pancreatic tissue analyses.
- Synthesis of existing literature on prohormone processing in T1D.
- Identification of knowledge gaps and future research needs.
Main Results:
- Reduced prohormone processing is consistently observed in T1D.
- Alterations in expression and processing impact islet function.
- The precise etiologies and consequences require further investigation.
Conclusions:
- Altered prohormone processing may serve as a T1D biomarker.
- This could inform personalized therapeutic strategies.
- It may also help identify disease-specific endotypes.
Related Concept Videos
01:05Insulin Secretory Vesicles
6.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.6K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
742
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
742
01:22Diabetes Mellitus: Overview and Type I Subtype
4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
01:20Pathophysiology of Diabetes
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
01:16Hormones Regulating Blood Glucose
5.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
5.4K